DERMATA THERAPEUTICS
Dermata is a development-stage biotechnology company that focuses on making major advancements in the treatment of serious diseases treated by dermatologists. Its business strategy is to identify and develop innovative products that move into clinical trials to demonstrate efficacy and safety in a variety of diseases. They currently exploring the use of a unique botanical product with multiple proposed mechanisms of action in order to treat acne. It was founded in 2014 and headquartered in Encinitas, California.
DERMATA THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2014-01-01
Address:
Encinitas, California, United States
Country:
United States
Website Url:
http://www.dermatarx.com
Total Employee:
1+
Status:
Active
Contact:
858-756-2480
Email Addresses:
[email protected]
Total Funding:
20.56 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Apache Euro Microsoft Exchange Online Amazon
Current Employees Featured
Founder
Stock Details
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Dermata Therapeutics
Official Site Inspections
http://www.dermatarx.com Semrush global rank: 5.57 M Semrush visits lastest month: 1.52 K
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Dermata Therapeutics"
About Us — Dermata
Dermata is currently focused on developing multiple unique products derived from a natural source, for the treatment of a variety of skin diseases and conditions.See details»
Dermata
Dermata is a clinical-stage biotechnology company founded in late 2014 focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.See details»
Corporate Governance :: Dermata Therapeutics, Inc. (DRMA)
Steven J. Mento, Ph.D. serves as a director on the board of directors of Conatus Pharmaceuticals Inc. since 2005, and from 2005 to 2012, Dr. Mento served as chairman of Conatus’ board of …See details»
Company — Dermata
Dermata is currently focused on developing multiple unique products derived from a natural source, for the treatment of a variety of skin diseases and conditions.See details»
Company Information :: Dermata Therapeutics, Inc. (DRMA)
We are a clinical-stage biotechnology company founded in 2014 focused on developing and commercializing products for the treatment of various skin disease and multiple aesthetic skin …See details»
Dermata Therapeutics - Crunchbase Company Profile & Funding
Dermata is a development-stage biotechnology company that focuses on making major advancements in the treatment of serious diseases treated by dermatologists.See details»
Dermata Therapeutics | MedPath
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the …See details»
Dermata Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Investors: Sean Proehl [email protected] SOURCE: Dermata Therapeutics View the original press release on accesswire.com. Phase 3. ... The statistics for drugs in the Pipeline is the …See details»
Dermata Therapeutics - Overview, News & Similar companies
View Dermata Therapeutics (www.dermatarx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Board Committees :: Dermata Therapeutics, Inc. (DRMA)
From 1997 to 2005, Dr. Mento was President, Chief Executive Officer and a member of the board of directors of Idun Pharmaceuticals, Inc. Dr. Mento guided Idun during its transition from a …See details»
Dermata Therapeutics, Inc. | LinkedIn
Dermata Therapeutics, Inc. (Nasdaq: DRMA) is a clinical-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions.See details»
Investor Relations :: Dermata Therapeutics, Inc. (DRMA)
Oct 8, 2024 We are a clinical-stage biotechnology company founded in 2014 focused on developing and commercializing products for the treatment of various skin disease and …See details»
Contact - Dermata
We are also looking to for strategic partners for development of DMT410. If you possess a product which fits one of our core areas of focus, dermatology or ophthalmology, or are interested in …See details»
Dermata Company Profile 2024: Stock Performance & Earnings
Dermata General Information Description. Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing …See details»
DMT-410 - Drug Targets, Indications, Patents - Synapse - Patsnap
Originator Organization. Dermata Therapeutics, Inc. Active Organization-Inactive Organization. Dermata Therapeutics, Inc. Drug Highest Phase Pending ... California. For more information, …See details»
About DERMATA THERAPEUTICS, INC. | DxMultiomics
Dermatarx.com. Mark. Dermata Therapeutics, Inc. is a clinical-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions. The Company's lead …See details»
Dermata Receives Approval from FDA for the Proprietary Name …
1 day ago Dermata Therapeutics is a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin diseases and conditions. The Company's lead product …See details»
Product Pipeline — Dermata
DMT310. DMT310 is our lead product candidate, developed from our Spongilla platform technology that is currently in Phase 3 clinical trials for the treatment of acne. The unique …See details»
Dermata Receives Approval from FDA for the ... - The Globe and Mail
1 day ago ACCESSWIRE Press Release. - Xyngari (formerly DMT310) is currently being studied in Phase 3 for the treatment of acne, with topline results from the first Phase 3 STAR-1 study …See details»
Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 …
Dec 3, 2024 Dermata Therapeutics is a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions and diseases. The Company's lead product …See details»